BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 31 filers reported holding BIOLIFE SOLUTIONS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,124,000 | +53.3% | 64,200 | 0.0% | 0.42% | +43.9% |
| Q2 2018 | $733,000 | +185.2% | 64,200 | +28.4% | 0.29% | +116.2% |
| Q1 2018 | $257,000 | -14.3% | 50,000 | 0.0% | 0.14% | -13.4% |
| Q4 2017 | $300,000 | +4.9% | 50,000 | 0.0% | 0.16% | +12.1% |
| Q3 2017 | $286,000 | – | 50,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
| Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
| Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
| GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
| Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
| Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
| Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
| Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
| MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |